Manufacturing Made Simple Podcast

Manufacturing Made Simple Podcast

By Andrew CheungBusinessManagement
Download on the App Store

Manufacturing Made Simple Podcast episodes

  • 024 - Six Months In (Retrospective & Question of the Month)

    Andrew reflects on the first 24 episodes, answers a final question of the month, shares what surprised him most about the audience and the questions they asked, and previews what the next season will cover. A genuine celebration of the community built and a forward-looking note on where the show goes next.


    IG: @ManufacturingMadeSimplePod

    19 min
  • 023 - Green Manufacturing Is Not Optional Anymore

    Green chemistry in personal care, pharmaceutical waste and solvent management, sustainable packaging trade-offs, biosimilars and what they signal about the future of pharmaceutical manufacturing. Andrew explains how consumer demand and regulatory pressure are converging to make sustainability a manufacturing imperative, not a marketing differentiator.


    IG: @ManufacturingMadeSimplePod

    24 min
  • 022 - What the Failure Reports Don't Tell You — Part 2 of 2

    A product recall or launch failure is a masterclass in what not to do. Andrew analyzes common failure modes across bothindustries from stability surprises, regulatory rejection, API shortage, CMO quality failures and shows how postmortem thinking can become a proactive design tool.


    IG: @manufacturingmadesimplepod

    27 min
  • 021 - From Lab Bench to Market — Part 1 of 2

    The stage-gate framework applied to both personal care and pharmaceutical product development. Andrew walks throughgo/no-go decision checkpoints, scale-up challenges, contract manufacturer selection criteria, and the launch readiness checklist that separates brands that launch on schedule from those that don't.


    IG: @manufacturingmadesimplepod

    26 min
  • 019 - The Smart Factory

    Automation, AI, and digital tools reshaping personal care and pharmaceutical manufacturing such as MES, ERP, and LIMS systems in context, AI for defect detection and process optimization, predictive maintenance, and the real barriers to adoption for mid-size manufacturers who want the ROI without the enterprise infrastructure spend.


    IG: @manufacturingmadesimplepod

    30 min
  • 017 - The Supply Chain Reality Check — Part 1 of 2

    Where do raw materials and APIs actually come from? Andrew traces the journey of an ingredient from source to factory, explains single-source risk and supplier vetting, and addresses the concentration of global API manufacturing in China and India along with why that matters to anyone working in pharmaceutical manufacturing.


    IG: @manufacturingmadesimplepod

    25 min
  • Bonus Episode - RAS On RAS Off, The RAS Wall Falls

    For over 40 years, a protein called RAS was considered "undruggable" until this week. The FDA just approved the first-ever targeted therapy built specifically to block RAS, the mutation driving over 90% of pancreatic cancer cases, and did it months ahead of schedule.

    In this bonus episode, Andrew Cheung breaks down what the headlines are missing: why this approval is as much a manufacturing and regulatory story as a clinical one. We cover what the FDA's own language about review speed signals for the industry right now, how commercial launch readiness gets built in parallel with a filing rather than after it, and why the shift from an "undruggable" target to a once-daily oral tablet has real implications for scalability and access — not just chemistry.

    If you work in pharmaceutical manufacturing, regulatory affairs, quality, or you're building a product-based brand and want to understand how fast-moving approvals like this actually happen behind the scenes, this one's for you.

    In this episode:

    • What actually got approved, and why the RAS target mattered for decades
    • Why the FDA's "ahead of schedule" language is worth paying attention to
    • How manufacturing and regulatory strategy move in lockstep before an approval, not after
    • What oral small-molecule formats mean for scalability versus biologics

    IG: @manufacturingmadesimplepod

    11 min

About Manufacturing Made Simple Podcast

From the publisher's feed

I am a seasoned industry executive with over 15 years of experience in personal care and pharmaceutical manufacturing sector. I’ve led cross-functional teams from R&D to regulatory approval, supply chain optimization, product launch, and product lifecycle management. My deep understanding of the end-to-end manufacturing process makes me uniquely positioned to break down complex topics into digestible, actionable insights for professionals, entrepreneurs, and students making a name for themselves in the industry.